212 related articles for article (PubMed ID: 21435460)
1. Cytotoxic T lymphocytes efficiently recognize human colon cancer stem-like cells.
Inoda S; Hirohashi Y; Torigoe T; Morita R; Takahashi A; Asanuma H; Nakatsugawa M; Nishizawa S; Tamura Y; Tsuruma T; Terui T; Kondo T; Ishitani K; Hasegawa T; Hirata K; Sato N
Am J Pathol; 2011 Apr; 178(4):1805-13. PubMed ID: 21435460
[TBL] [Abstract][Full Text] [Related]
2. An adoptive T cell immunotherapy targeting cancer stem cells in a colon cancer model.
Gao XY; Wang XL
J BUON; 2015; 20(6):1456-63. PubMed ID: 26854441
[TBL] [Abstract][Full Text] [Related]
3. Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer-Initiating Cells and Is a Potent Target of Immunotherapy.
Morita R; Hirohashi Y; Torigoe T; Ito-Inoda S; Takahashi A; Mariya T; Asanuma H; Tamura Y; Tsukahara T; Kanaseki T; Kubo T; Kutomi G; Mizuguchi T; Terui T; Ishitani K; Hashino S; Kondo T; Minagawa N; Takahashi N; Taketomi A; Todo S; Asaka M; Sato N
Clin Cancer Res; 2016 Jul; 22(13):3298-309. PubMed ID: 26861454
[TBL] [Abstract][Full Text] [Related]
4. Establishment and Analysis of Cancer Stem-Like and Non-Cancer Stem-Like Clone Cells from the Human Colon Cancer Cell Line SW480.
Takaya A; Hirohashi Y; Murai A; Morita R; Saijo H; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Tamura Y; Takemasa I; Kondo T; Sato N; Torigoe T
PLoS One; 2016; 11(7):e0158903. PubMed ID: 27415781
[TBL] [Abstract][Full Text] [Related]
5. Cep55/c10orf3, a tumor antigen derived from a centrosome residing protein in breast carcinoma.
Inoda S; Hirohashi Y; Torigoe T; Nakatsugawa M; Kiriyama K; Nakazawa E; Harada K; Takasu H; Tamura Y; Kamiguchi K; Asanuma H; Tsuruma T; Terui T; Ishitani K; Ohmura T; Wang Q; Greene MI; Hasegawa T; Hirata K; Sato N
J Immunother; 2009 Jun; 32(5):474-85. PubMed ID: 19609239
[TBL] [Abstract][Full Text] [Related]
6. The feasibility of Cep55/c10orf3 derived peptide vaccine therapy for colorectal carcinoma.
Inoda S; Morita R; Hirohashi Y; Torigoe T; Asanuma H; Nakazawa E; Nakatsugawa M; Tamura Y; Kamiguchi K; Tsuruma T; Terui T; Ishitani K; Hashino S; Wang Q; Greene MI; Hasegawa T; Hirata K; Asaka M; Sato N
Exp Mol Pathol; 2011 Feb; 90(1):55-60. PubMed ID: 20950610
[TBL] [Abstract][Full Text] [Related]
7. Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8+ cytotoxic T lymphocytes.
Bergmann-Leitner ES; Abrams SI
Cancer Immunol Immunother; 2001 Nov; 50(9):445-55. PubMed ID: 11761438
[TBL] [Abstract][Full Text] [Related]
8. Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells.
Hirohashi Y; Torigoe T; Inoda S; Takahashi A; Morita R; Nishizawa S; Tamura Y; Suzuki H; Toyota M; Sato N
Immunotherapy; 2010 Mar; 2(2):201-11. PubMed ID: 20635928
[TBL] [Abstract][Full Text] [Related]
9. LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution.
Kobayashi S; Yamada-Okabe H; Suzuki M; Natori O; Kato A; Matsubara K; Jau Chen Y; Yamazaki M; Funahashi S; Yoshida K; Hashimoto E; Watanabe Y; Mutoh H; Ashihara M; Kato C; Watanabe T; Yoshikubo T; Tamaoki N; Ochiya T; Kuroda M; Levine AJ; Yamazaki T
Stem Cells; 2012 Dec; 30(12):2631-44. PubMed ID: 23081779
[TBL] [Abstract][Full Text] [Related]
10. GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy.
Miyata H; Hirohashi Y; Yamada S; Yanagawa J; Murai A; Hashimoto S; Tokita S; Hori K; Abe T; Kubo T; Tsukahara T; Kanaseki T; Shinohara N; Torigoe T
Cancer Immunol Immunother; 2022 Apr; 71(4):795-806. PubMed ID: 34405274
[TBL] [Abstract][Full Text] [Related]
11. Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells.
Brown CE; Starr R; Martinez C; Aguilar B; D'Apuzzo M; Todorov I; Shih CC; Badie B; Hudecek M; Riddell SR; Jensen MC
Cancer Res; 2009 Dec; 69(23):8886-93. PubMed ID: 19903840
[TBL] [Abstract][Full Text] [Related]
12. A subpopulation of CD24⁺ cells in colon cancer cell lines possess stem cell characteristics.
Ke J; Wu X; Wu X; He X; Lian L; Zou Y; He X; Wang H; Luo Y; Wang L; Lan P
Neoplasma; 2012; 59(3):282-8. PubMed ID: 22329848
[TBL] [Abstract][Full Text] [Related]
13. Heat shock protein DNAJB8 is a novel target for immunotherapy of colon cancer-initiating cells.
Morita R; Nishizawa S; Torigoe T; Takahashi A; Tamura Y; Tsukahara T; Kanaseki T; Sokolovskaya A; Kochin V; Kondo T; Hashino S; Asaka M; Hara I; Hirohashi Y; Sato N
Cancer Sci; 2014 Apr; 105(4):389-95. PubMed ID: 24450541
[TBL] [Abstract][Full Text] [Related]
14. Aldehyde Dehydrogenese-1 High Cancer Stem-like Cells/Cancer-initiating Cells Escape from Cytotoxic T Lymphocytes due to Lower Expression of Human Leukocyte Antigen Class 1.
Shirosaki T; Kawai N; Ebihara Y; Murai A; Kubo T; Morita R; Murata K; Kanaseki T; Tsukahara T; Shichinohe T; Hirohashi Y; Hirano S; Torigoe T
Anticancer Res; 2024 May; 44(5):1877-1883. PubMed ID: 38677758
[TBL] [Abstract][Full Text] [Related]
15. Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy.
Kubo T; Takigawa N; Osawa M; Harada D; Ninomiya T; Ochi N; Ichihara E; Yamane H; Tanimoto M; Kiura K
Cancer Sci; 2013 Jan; 104(1):78-84. PubMed ID: 23066953
[TBL] [Abstract][Full Text] [Related]
16. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
[TBL] [Abstract][Full Text] [Related]
17. ABCG2-meditated multidrug resistance and tumor-initiating capacity of side population cells from colon cancer.
Xie ZY; Lv K; Xiong Y; Guo WH
Oncol Res Treat; 2014; 37(11):666-8, 670-2. PubMed ID: 25427584
[TBL] [Abstract][Full Text] [Related]
18. Autologous CTL response against cancer stem-like cells/cancer-initiating cells of bone malignant fibrous histiocytoma.
Kano M; Tsukahara T; Emori M; Murase M; Torigoe T; Kawaguchi S; Wada T; Yamashita T; Sato N
Cancer Sci; 2011 Aug; 102(8):1443-7. PubMed ID: 21518139
[TBL] [Abstract][Full Text] [Related]
19. Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.
Brossart P; Stuhler G; Flad T; Stevanovic S; Rammensee HG; Kanz L; Brugger W
Cancer Res; 1998 Feb; 58(4):732-6. PubMed ID: 9485028
[TBL] [Abstract][Full Text] [Related]
20. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.
Su P; Yang Y; Wang G; Chen X; Ju Y
Int J Oncol; 2018 Sep; 53(3):1343-1353. PubMed ID: 29956726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
